Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels

Journal of Neurophysiology

Volumn 95, Issue 3, 2006, Pages 1491-1498

  Wang, R ^a   Cruciani Guglielmacci, C ^b   Migrenne, S ^b   Magnan, C ^b   Cotero, V E ^a   Routh, V H ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; OLEIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN SLICE; CELL POPULATION; CELL SUBPOPULATION; ENERGY BALANCE; FATTY ACID METABOLISM; GLUCOSE HOMEOSTASIS; HYPOTHALAMUS; MALE; NERVE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SENSOR; ACTION POTENTIAL; ANIMAL; CELL CULTURE; CELL MEMBRANE POTENTIAL; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR FLUID; METABOLIC CLEARANCE RATE; METABOLISM; NERVE CELL NETWORK; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; ARCUATE NUCLEUS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; FATTY ACIDS; GLUCOSE; MALE; MEMBRANE POTENTIALS; METABOLIC CLEARANCE RATE; NERVE NET; NEURONS; OLEIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33646012618     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00697.2005     Document Type: Article

References (41)

1. Best L, Brown PD, and Tomlinson S. Anion fluxes, volume regulation and electrical activity in the mammalian pancreatic beta-cell. Exp Physiol 82: 957-966, 1997.
2. Best L, Yates AP, Decher N, Steinmeyer K, and Nilius B. Inhibition of glucose-induced electrical activity in rat pancreatic [beta]-cells by DCPIB, a selective inhibitor of volume-sensitive anion currents. Eur J Pharmacol 489: 13-19, 2004.
3. Brantrom R, Aspinwall CA, Valimaki S, Ostensson CG, Tibell A, Eckhard M, Brandhorst H, Corkey BE, Berggren PO, and Larsson O. Long-chain CoA esters activate human pancreatic beta-cell KATP channels: potential role in type 2 diabetes. Diabetologia 47: 277-283, 2004.
4. Clement L, Cruciani-Guglielmacci C, Magnan C, Vincent M, Douared L, Orosco M, Assimacopoulos-Jeannet F, Penicaud L, and Ktorza A. Intracerebroventricular infusion of a triglyceride emulsion leads to both altered insulin secretion and hepatic glucose production in rats. Pfluegers Arch 445: 375-380, 2002.
5. Cruciani-Guglielmacci C, Hervalet A, Douared L, Sanders NM, Levin BE, Ktorza A, and Magnan C. Beta oxidation in the brain is required for the effects of non-esterified fatty acids on glucose-induced insulin secretion in rats. Diabetologia 47: 2032-2038, 2004.
6. De Vries MG, Arseneau LM, Lawson ME, and Beverly JL. Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia. Diabetes 52: 2767-2773, 2003.
7. Ding ST, Schinckel AP, Weber TE, and Mersmann HJ. Expression of porcine transcription factors and genes related to fatty acid metabolism in different tissues and genetic populations. J Anim Sci 78: 2127-2134, 2000.
8. Evans ML, Matyka K, Lomas J, Pernet A, Cranston ICP, Macdonald I, and Amiel SA. Reduced counterregulation during hypoglycemia with raised circulating nonglucose lipid substrates: evidence for regional differences in metabolic capacity in the human brain? J Clin Endocrinol Metab 83: 2952-2959, 1998.
9. 2+ channel and link to insulin release. Am J Physiol http://ajpendo.physiology.org/cgi/content/abstract/00035.2005v1 [May 24, 2005].
10. Hallows KR, Raghuram V, Kemp BE, Witters LA, and Foskett JK. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 105: 1711-1721, 2000.
11. Hepp S, Gerich FJ, and Mueller M. Sulfhydryl oxidation reduces hippocampal susceptibility to hypoxia-induced spreading depression by activation BK-channels. J Neurophysiol http://jn.physiology.org/cgi/reprint/00291. 2005v1 [May 4, 2005].
12. Honen BN, Saint DA, and Laver DR. Suppression of calcium sparks in rat ventricular myocytes and direct inhibition of sheep cardiac RyR channels by EPA, DHA and oleic acid. J Membr Biol 196: 95-103, 2003.
13. Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH, and Ronnett GV. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem 279: 19970-19976, 2004.
14. Kim EK, Miller I, Landree LE, Borisy-Rudin FF, Brown P, Tihan T, Townsend CA, Witters LA, Moran TH, Kuhajda FP, and Ronnett GV. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am J Physiol 283: E867-E879, 2002.
15. Lam TKT, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, Aguilar-Bryan L, Schwartz GJ, and Rossetti L. Hypothalamic sensing of circulating fatty acids in required for glucose homeostasis. Nat Med 11: 320-327, 2005.
16. Landree LE, Hanlon AL, Strong DW, Rumbaugh G, Miller IM, Thupari JN, Connolly EC, Huganir RL, Richardson C, Witters LA, Kuhajda FP, and Ronnett GV. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. J Biol Chem 279: 3817-3827, 2004.
17. Liu Y and Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol 29: 305-311, 2002.
18. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, and Kuhajda FP. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288: 2379-2381, 2000.
19. Makimura H, Mizuno TM, Yang XJ, Silverstein J, Beasley J, and Mobbs CV. Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. Diabetes 50: 733-739, 2001.
20. Miller I, Ronnett GV, Moran TH, and Aja S. Anorexigenic C75 alters c-Fos in mouse hypothalamic and hindbrain subnuclei. Neuroreport 15: 925-929, 2004.
21. Obici S, Feng Z, Arduini A, Conti R, and Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9: 756-761, 2003.
22. Oishi K, Zheng B, and Kuo JF. Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid. J Biol Chem 265: 70-75, 1990.
23. Oomura Y, Nakamura T, Sugimori M, and Yamada Y. Effect of free fatty acid on the rat lateral hypothalamic neurons. Physiol Behav 14: 483-486, 1975.
24. 2+ fluxes in rabbit T-tubule membranes. Arch Biochem Biophys 434: 344-351, 2005.
25. Phillis J, Song D, and O'Regan M. Melittin enhances amino acid and free fatty acid release from the in vivo cerebral cortex. Brain Res 847: 270-275, 1999.
26. Pocai A, Lam TKT, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, and Rossetti L. Hypothalamic KATP channels control hepatic glucose production. Nature 434: 1026-1031, 2005.
27. Ramirez-Exposito M, Martinez-Martos J, Mayas M, Garcia M, Prieto I, Arechaga G, and Ramirez M. Oleate, linoleate and cholesterol differently modify aspartyl- and glutamyl-aminopeptidase activities in primary cultures of rat astrocytes. Comp Biochem Physiol 128: 113-118, 2001.
28. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
29. Sanders NM and Ritter S. Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation. Diabetes 49: 1865-1874, 2000.
30. Shu IW, Lindenberg DL, Mizuno TM, Roberts JL, and Mobbs CV. The fatty acid synthase inhibitor cerulenin and feeding, like leptin, activate hypothalamic pro-opiomelanocortin (POMC) neurons. Brain Res 985: 1-12, 2003.
31. Silver IA and Erecinska M. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons. J Neurophysiol 79: 1733-1745, 1998.
32. Song Z and Routh VH. Differential effects of glucose and lactate on glucosensing neurons in the ventromedial hypothalamic nucleus (VMN). Diabetes 54: 15-22, 2005.
33. Takahashi KA, Smart JL, Liu H, and Cone RD. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator. Endocrinology 145: 184-193, 2004.
34. Tewari KP, Malinowska DH, Sherry AM, and Cuppoletti J. PKA and arachidonic acid activation of human recombinant CIC-2 chloride channels. Am J Physiol Cell Physiol 279: C40-C50, 2000.
35. Thupari JN, Landree LE, Ronnett GV, and Kuhajda FP. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc Natl Acad Sci USA 99: 9498-9502, 2002.
36. Tu Y, Thupari JN, Kim EK, Pinn ML, Moran TH, Ronnett GV, and Kuhajda FP. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure. Endocrinology 146: 486-493, 2005.
37. Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W, and Routh VH. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53: 1959-1965, 2004.
38. Witt MR and Nielsen M. Characterization of the influence of unsaturated free fatty acids on brain GABA/benzodiazepine receptor binding in vitro. J Neurochem 62: 1432-1439, 1994.
39. Xu WX, Kim SJ, Kang TM, Rhee JS, and Kim WK. Volume-sensitive chloride current activated by hyosmotic swelling in antral gastric myocytes of the guinea-pig. Pfluegers Arch 435: 9-19, 1997.
40. Yang N, Kays JS, Skillman TR, Burris L, Seng TW, and Hammond C. C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl CoA. J Pharmacol Exp Ther 312: 127-133, 2005.
41. Zheng HF, Li XL, Jin ZY, Sun JB, and Xu WX. Effects of unsaturated fatty acids on calcium-activation potassium current in gastric myocytes of guinea pigs. World J Gasteroenterol 11: 672-675, 2005.